Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials. Arch Ital Urol Androl. 2024;96(4). doi:10.4081/aiua.2024.12833